ALKERMES | ALKS - EPS Earnings Per Share


ALKERMES reported $0.29 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 -0.4 0.13 Apr/29
FY2025Q4 Dec/2025 0.29 0.42 1.05 Feb/25
FY2025Q3 Sep/2025 0.49 0.4 0.73 Oct/28
FY2025Q2 Jun/2025 0.52 0.39 0.72 Jul/29
FY2025Q1 Mar/2025 0.13 0.39 0.43 May/01




Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
ALKERMES USD 0.29 0.2 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Coherus Biosciences USD -0.43 0.06 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
Heron Therapeutics USD -0.02 0.02 Dec/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
J&J USD 2.46 0.34 Dec/2025
Malin Corporation EUR -0.06 0.1 Dec/2023
Merck USD 2.04 0.54 Dec/2025
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Otsuka Holdings JPY 124.25 110.44 Dec/2025
Ovoca Bio EUR -0.07 0.04 Jun/2022
Pfizer USD 0.66 0.21 Dec/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025